References
- Zhao G, Zang S-Y, Jiang Z-H, Chen YY, Ji XH, Lu BF, . Post-ischemic administration of liposome-encapsulated luteolin prevents against ischemia reperfusion injury in a rat middle cerebral artery occlusion model. J Nutr Biochem. 2010; doi:10.1016/j.jnutbio. 2010.07.014.
- Kao T-K, Ou Y-C, Lin S-Y, Pan HC, Song PJ, Raung SL, . Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J Nutr Biochem. 2010; doi:10.1016/j.jnutbio.2010.01.011
- Rezai-Zadeh K, Ehrhart J, Bai Y, Sanberg PR, Bickford P, Tan J, . Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J Neuroinflammation. 2008;5:41.
- Amin ARMR, Wang D, Zhang H, Peng S, Shin HJ, Brandes JC, . Enhanced anti-tumor activity by the combination of the natural compounds (‚àí)-Epigallocatechin-3-gallate and luteolin. J Biol Chem. 2010;285:34557–65.
- Wölfle U, Esser PR, Simon-Haarhaus B, Martin SF, Lademann Jr, Schempp CM. UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo. Free Radic Biol Med. 2011; doi:10.1016/j.freeradbiomed.2011.01.027
- http://www.immunobiotics.com/
- www.fda.gov/ohrms/dockets/DOCKETS/.../95s-0316-rpt0150-01-vol108.pdf